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Abstract
Objectives To evaluate the feasibility and 6 months clini-
cal result of sectioning of the transverse carpal ligament
(TCL) and median nerve decompression after ultra-mini-
mally invasive, ultrasound-guided percutaneous carpal
tunnel release (PCTR) surgery.
Methods Consecutive patients with carpal tunnel syn-
drome were enrolled in this descriptive, open-label study.
The procedure was performed in the interventional radi-
ology room. Magnetic resonance imaging was performed at
baseline and 1 month. The Boston Carpal Tunnel Ques-
tionnaire was administered at baseline, 1, and 6 months.
Results 129 patients were enrolled. Significant decreases
in mean symptom severity scores (3.3 ± 0.7 at baseline,
1.7 ± 0.4 at Month 1, 1.3 ± 0.3 at Month 6) and mean
functional status scores (2.6 ± 1.1 at baseline, 1.6 ± 0.4 at
Month 1, 1.3 ± 0.5 at Month 6) were noted. Magnetic
resonance imaging showed a complete section of all TCL
and nerve decompression in 100% of patients. No com-
plications were identified.
Conclusions Ultrasound-guided PCTR was used success-
fully to section the TCL, decompress the median nerve, and
reduce self-reported symptoms.
Keywords Carpal tunnel syndrome  Magnetic
resonance imaging  Interventional ultrasound 
Minimally invasive surgical procedures  Surveys and
questionnaires
Introduction
Carpal tunnel syndrome, which is a common neuropathy, is
caused by the transverse carpal ligament (TCL) com-
pressing the median nerve at the base of the palm. Most
often, when nonsurgical methods, such as rest, splinting,
physical therapy, and corticosteroid injections, do not
alleviate symptoms sufficiently, a surgical release of the
median nerve is achieved by sectioning the TCL.
Open carpal tunnel releases (OCTR) have been per-
formed successfully for many years [1]. These procedures
are, however, associated with 60–80 mm scars, lengthy
recovery periods (25 days), and a complication rate of
*1% [2]. Endoscopic techniques (ECTR) have been
developed as a less invasive alternative. Although endo-
scopic procedures reduce scarring to 10 mm, this technique
can be challenging because the initial placement of the
trocar is blind and during the procedure, vision is limited
by the narrow range of the endoscope. In fact, meta-anal-
yses have underscored the impact of low visibility by
showing that risk of transient nerve damage is higher with
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reoperation rates are, however, similar; and other post-
operative variables, such as recovery time, strength during
the early post-operative period, and wound problems (scar
tenderness, infection, hypertrophic scarring), are signifi-
cantly better with ECTR than with OCTR [3, 4].
Recent developments in sonography now allow us to
demarcate superficial soft tissues and to identify very small
anatomic and pathologic details. In the context of carpal
tunnel release surgery, a technique that incorporates the
careful delineation of the thenar motor branch of the
median nerve, for instance, may help reduce the risk of
complications due to nerve damage [5]. To this effect,
ultrasound-guided percutaneous carpal tunnel release
(PCTR) has been developed. This technique makes use of
the detailed anatomical information that can be gathered
from continuous ultrasound monitoring and combines it
with the advantages of minimally invasive percutaneous
surgery [6–11].
Studies on cadavers have shown that the transverse
carpal ligament can be transected successfully using
PCTR [7, 8, 12, 13]; and clinical studies have shown that
PCTR is effective and well tolerated [6, 9, 11, 14]. None
of these clinical studies, however, have documented
outcomes using magnetic resonance imaging (MRI),
which is the gold standard for confirming complete sec-
tioning of transverse carpal ligament and surgical
decompression of the median nerve [15–17]. Furthermore,
in all these studies the operator was not an interventional
musculoskeletal radiologist, and it is unclear how many
years of experience the operator had with hand ultrasound
and percutaneous ultrasound-guided procedures. The pri-
mary objective of this prospective clinical study is to
assess the feasibility and safety of PCTR when it was
performed by an interventional radiologist and to use
MRI to document it. The secondary objective was to
examine efficacy.
Methods
In this prospective, open-label PCTR study, consecutive
patients were enrolled if they had been referred for carpal
tunnel surgery, had carpal tunnel syndrome symptoms for
more than 6 months, had a confirmation of diagnosis by
electromyogram, and had failed medical treatment. Patients
with a history of carpal tunnel release surgery were
excluded. Informed consent was obtained from all indi-
viduals included in the study. Institutional Review Board
approval was obtained for this study.
Sonographic evaluations and surgery were performed by
one interventional radiologist with 12 years of experience
in musculoskeletal sonography. All PCTR were ambula-
tory and were performed in the interventional radiology
room under local anesthesia (Fig. 1). Just prior to starting
the procedure, the median nerve, the ulnar nerve, the vas-
cular palmar arch, and the transverse carpal ligament were
mapped using a Hitachi Noblus ultrasound scanner (Hitachi
Medical Systems Europe, Zug, Switzerland) with an
18 MHz probe. Emphasis was placed on the charting of the
motor and sensitive branches of the median nerve and on
the identification anatomic variations. Results of this
sonographic evaluation were used to determine the area of
incision and a safe release path [6, 8, 11].
The retrograde division of the transverse carpal ligament
was then carried out using the 3-step UGS (Ultrasound-
Guided Surgery) with a distal antebrachial approach.
During step 1, local anesthesia was administered using a
26 gage needle at the wrist crease, and using a 22 gage
needle inside the carpal tunnel just below the TCL centered
above the capitatum and lunatum bone. 3 cc of local
anesthetic was able to fill and expand the space between the
median nerve, the hook of the hamatum, the TCL and the
flexor tendon called the longitudinal safe zone. During step
2, a point of entry at the proximal wrist crease was pierced
through the deepest fibrous layer using a scalpel 16. During
step 3, an Acufex 3.0-mm hook knife (010600; Smith &
Nephew PLC, London, England) was then advanced
through the prepared longitudinal safe zone to the distal
TCL. The hook knife was than rotated to point up to ensure
that the blade was perpendicular to and hooked onto the
TCL than pulled to perform the retrograde section. All
steps including anesthesia were performed under
Fig. 1 Standard table for PCTR. H Hook knife. U Ultrasound probe
in a sterile covering
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ultrasonographic guidance (Fig. 2). Follow-up appoint-
ments took place 4 days, 1, and 6 months after surgery.
Evaluations
Surgical procedure criteria were duration of the PCTR (not
including preliminary ultrasound mapping) and total time
in the procedure room.
The main clinical evaluation was the Boston Carpal
Tunnel Questionnaire (BCTQ), which was administered
prior to the procedure (baseline), 1 month after the pro-
cedure (Month 1), and at the end of the study (Month 6).
The BCTQ is a 19-question, self-administered, patient
questionnaire that evaluates severity of symptoms (11
questions) and functional status (8 questions) using a
5-point scale (1 = best score and 5 = worst score)
[18, 19]. Additional clinical variables included evaluation
of the scar and post-operative complications at Day 4,
Month 1, and Month 6.
Magnetic resonance imaging was performed prior to
surgery and 1 month after surgery using T1-weighted and
T2-weighted fat saturation sequences (Magnetom
Essenza 1.5T [Siemens, Erlangen, Germany]). The main
imaging variable, the degree of sectioning of the TCL
Fig. 2 Ultrasound monitoring of the ultra-minimally invasive carpal
tunnel release. A axial view: hook knife position (arrow) between the
median nerve (M) and ulnar artery (A) and below the transverse
carpal ligament (arrowhead); the curved line represent the space
expand with local anesthetic between the carpal tunnel ligament, the
flexor tendons, the hook of the hamatum and the median nerve.
B Longitudinal view positioning of the hook knife (arrow) at the
distal cutting point below the TCL (arrowhead). C longitudinal view
pulling back on the hook knife (arrow) while applying volar pressure
for retrograde releasing of the TCL (arrowhead). D ultrasound control
of the TCL release. Double arrow represents the free edges of the
TCL that have been cut releasing the median nerve (NMedian). Bone
landmarks; H is the hook of the hamatum, C is the capitatum
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(absent, partial, or complete) and the size of the discrete
gap in the TCL were determined from T2 axial image
slices. T2 axial images were also used to evaluate the
median nerve. The cross-sectional area of the median nerve
was determined at the level of the hook of the hamate
where the nerves tended to be most compressed. Decom-
pression of the nerve was scored based on its position
compared to the line joining the hook of hamate to the
ridge of the trapezium. Position was defined as deep if the
nerve was above the line; intermediary if the nerve crossed
the line; superficial if nerve was under the line [17].
Decompression was considered successful if the nerve
location moved from a deep position to a more superficial
position after PCTR. Potential complications were also
assessed by MRI. Images were read independently by the
operating radiologist (DP) and by a radiologist (JS) who
was blinded to clinical outcome. Any discrepancies were
resolved by consensus.
Statistical Analysis
Descriptive statistics were used to describe results. Cate-
gorical variables are presented as percentages. Continuous
variables are presented as means and standard deviations
(SD). McNemar tests were used to compare categorical
variables. Student’s tests and Student’s t-tests for paired
samples were used to compare continuous variables. The
percentage of patients that showed a change in nerve
position before and after PCTR and 95% confidence
intervals were calculated. P-values were assessed at the
0.05 level. Statistical analyses were performed using SAS
version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
129 patients meeting study criteria were enrolled between
January 2015 and June 2016. Baseline, Day 4, and Month 1
data were collected for all patients. Month 6 follow-up
data, which were collected after a mean of
7.5 ± 2.8 months, were available for all patients. At
baseline, mean age was 61.5 ± 13.3 years. Most patients
were female (69.8%). Sixty-six patients (51.2%) needed
surgery on their right hand and sixty-three (48.8%) on their
left. Fifteen patients (11.6%) had a bifid median nerve. The
procedure lasted a mean of 5.8 ± 2.4 min. Mean time in
the procedure room was 23.2 ± 4.8 min. Scar length ran-
ged from 2.0 to 5.0 mm (Fig. 3).
No complications were reported at Day 4, Month 1, or
Month 6. At 6 months, 12 patients (9.3%) reported mini-
mal paresthesia. The BCTQ symptom severity score
improved in all patients from a mean of 3.3 ± 0.7 at
baseline to 1.7 ± 0.4 at Month 1 (Fig. 4A). The BCTQ
functional status score improved from a mean of 2.6 ± 1.1
at baseline to 1.6 ± 0.4 at Month 1 (Fig. 4B). Changes
from baseline to Month 1 were significant (p\ 0.0001 for
both domains). At Month 6, mean symptom severity score
was 1.3 ± 0.3 and mean functional status score was
1.3 ± 0.5. Changes from the 1-month time point to the
6-month time point were significant for both domains
(p\ 0.0001 for symptom severity and p = 0.0004 for
functional status).
Results of the MRI showed that a complete section of
the TCL along its length was achieved in 129 patients
(100%). The gap in the TCL measured a mean
5.1 ± 1.5 mm. At the level of the hamate bone, where the
nerves tended to be most compressed at baseline, mean
Fig. 3 Surgical scar for ultra-minimally invasive carpal tunnel release. Left skin incision with the hook knife introduced percutaneously at the
first available antebrachial skin crease in the left hand. Right, skin scar (arrow) just after
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nerve cross-sectional surface area increased from
8.9 ± 3.3 mm2 at baseline to 13.5 ± 3.7 mm2 at Month 1
(p\ 0.0001).
Nerve position changed in 79% of patients (95% con-
fidence interval: [66.8–91.2%]; Table 1). An example of
MRI images before and after successful PCTR is presented
in Fig. 5. After PCTR, the median nerve became rounder
and larger at the hamate level, and the nerve position
changed from being at the same level as the line joining the
hook of hamate and the ridge of the trapezium to being
below it.
Discussion
In this study, which included patients with moderate to
severe carpal tunnel syndrome (baseline BCTQ symptom
severity and functional status scores of 3.3 and 2.6,
respectively), we performed the retrograde division of the
transverse carpal ligament using an ultra-minimally inva-
sive ultrasound-guided percutaneous procedure. Recent
papers have described this technique [6, 9, 11, 14], but all
performed by orthopedist or interventional rheumatologist
with unknown years of experience with hand ultrasound;
therefore, there have been questions about their general-
izability with a large list of technical contraindications such
as a distance between the median nerve and the ulnar artery
less than 3 mm or anatomical variation of the median nerve
[20, 21]. Rojo in his cadaveric study concluded that PCTR
may be difficult for an orthopedist without previous
experience in ultrasound-guided procedures and should
develop his skills first with guided infiltration (8). In this
first study performed by an interventional radiologist with
more than ten years’ experience with hand ultrasound and
US-guided percutaneous procedure, there were no techni-
cal limitations.
One-month and 6-month post-operative clinical results
showed that mean BCTQ scores had improved signifi-
cantly, both in the symptom severity and the functional
status domains in all patients similar to that of OCTR and
ECTR (2). Magnetic resonance imaging results 1 month
after the procedure showed that the transverse carpal
ligament was completely sectioned in 100% of patients.
There were no intra or post-operative complications among
the patients. The clinical and MRI results of this study
show that ultrasound monitoring can be used successfully
by an interventional radiologist to guide incision points and
release paths and could be a good alternative to current
minimally invasive methods.
Magnetic resonance imaging was performed 1 month
after the procedure in order to confirm complete resection
of the TCL. We found that at the 1-month time point,
sectioning of the TCL was visible and that sectioning was
complete along its length in all 129 patients. Change in
nerve position compared to the line joining the hook of
hamate to the ridge of the trapezium is a measure of
decompression that can be assessed by MRI. More super-
ficial placement indicates better decompression. In 79% of
patients, the nerve position became more superficial after
the procedure, and in 88% of patients, no paresthesia was
reported at 6 months. The long-term significance of these
data is unknown, but Campagna et al. [17] showed that
Fig. 4 Boston Carpal Tunnel Questionnaire symptom and functional
domain scores before and after minimally invasive ultrasound-guided
percutaneous carpal tunnel release surgery. The Boston Carpal Tunnel
Questionnaire (BCTQ) was administered prior to the procedure (pre-
operative/baseline; N = 129), 1 month after the procedure (M1;
N = 129), and after 6 months of follow-up (M6; N = 129). The
BCTQ is a 19-question, self-administered patient questionnaire that
uses a 5-point scale (1 = best score and 5 = worst score). A Symptom
severity score (11 questions) and B Functional status score (8
questions). Bolded horizontal line represents the median. Black full
circle represents the mean
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insufficient change in nerve position was associated with
carpal tunnel syndrome recurrence. We can therefore sur-
mise that the incidence of recurrence, in our patient pop-
ulation would be low.
No nerve damage-related complications were identified
on Month 1 MRIs or reported during clinical evaluations.
These data, which were collected in a cohort that included
15 patients with a bifid median nerve, suggest that real-
time continuous ultrasound imaging provided sufficient
visual support to avoid nerve damage. Good clinical
outcomes and no clinical indication of nerve damage have
also been recorded in other studies that used ultrasound to
guide the procedure [6, 9, 11, 14]. As our study was not
designed to collect anatomical data about variations of the
palmar cutaneous branch and thenar motor branches and
was not sufficiently powered to enroll patients with a
large range of anatomic variations [20–22], larger studies
that include a wide range of anatomical presentations and
that specifically document anatomical variations will be
needed to determine complication rates in higher risk
patients.
We found that our technique was truly minimally
invasive as scar length ranged from 2.0 to 5.0 mm. Small
incision points imply less infection and less potential for
scar pain. Consistent with this observation, no pain or
infections were reported. By contrast, in OCTR and ECTR
studies, over 50% of patients report scar pain [23] and
patients have cited concerns about scar pain as a reason for
surgery cancellation [24]. Although the causes of scar pain
are not well understood, we can hypothesize that a smaller
incision will be associated with less superficial skin nerve
damage and therefore less scar discomfort. In fact, in the
comparative study by Nakamichi et al. [6], patients
reported less scar sensitivity with a 4 mm incision from
PCTR than with a 10–15 mm incision from mini-OCTR.
Short procedure duration times suggest less potential for
infection and lower procedure cost. The mean PCTR pro-
cedure duration was 6 min. These data contrast with that
reported by Lecoq et al. [14] who reported PCTR proce-
dure times of 19 min. In this study, the operator was an
interventional orthopedist or rheumatologist trained to
ultrasound. However, the number of years of experience
with hand ultrasound is unclear. We have to assume that, at
this early stage of procedure development, differences in
technique and training, particularly between rheumatolo-
gists, interventional radiologists, and surgeons, are likely to
affect the duration of this procedure, which has been
described by some as being technically demanding [11].
Lastly, this study is one of the first studies to perform
PCTR in the radiology intervention room [14]. The absence
of sepsis and complications supports the apparent feasi-
bility and safety of performing this procedure outside of the
operating room.
Limitations
In our study, efficacy was measured based on TCL sec-
tioning, nerve decompression, and patient-reported symp-
toms. Other measures such as grip strength and atrophy
were not measured. This represents a limitation in our
interpretation of efficacy as in some PCTR studies, sig-
nificant clinical improvement was nonetheless accompa-
nied by[30% of patients having atrophy in their hand and/
or below-average grip strength [9]. As these studies did not
use MRI to document complete sectioning and nerve
decompression, it is unclear whether these data reflect only
partial surgical success.
Furthermore, this is a single operator cohort study that
needs to be confirmed by a randomized multicenter con-
trolled trial evaluating safety and efficacy of PCTR versus
ECTR or OCTR.
Additional studies would be needed to understand the
relationship between the degree of sectioning and decom-
pression and symptoms such as grip strength.
Conclusions
In our study, we show that ultrasound-guided PCTR was
used successfully to section the transverse carpal ligament,
decompress the median nerve, and improve self-reported
symptoms. Magnetic resonance imaging results showed
Table 1 Median nerve position
1 month after percutaneous
carpal tunnel release (N = 129)
Position before PCTR Position after PCTR
Nerve above the line Nerve crosses the line Nerve under the line
Nerve above the line 12 (13.8%) 27 (31.0%) 48 (55.2%)
Nerve crosses the line 0 12 (30.8%) 27 (69.2%)
Nerve under the line 0 0 3 (100%)
Position of the nerve was compared to the line joining the hook of hamate to the ridge of the trapezium.
Decompression was considered successful if nerve location went from a deep to a superficial position:
nerve above the line (deepest), nerve crosses the line (intermediary); nerve under the line (most superficial).
PCTR percutaneous carpal tunnel release
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that outcomes were similar to those reported after OCTR
with a complete sectioning of the ligament and successful
decompression of the nerve.
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